We are live on ! Find out more
SGK

Steigerwald Gordon & Koch Portfolio holdings

AUM $1.01B Turnover 3.56%
1-Year Est. Return 15.33%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+15.33%
3 Year Est. Return
+59.48%
5 Year Est. Return
+77.26%
10 Year Est. Return
+288.1%
AUM
$1.01B
AUM Growth
+$34.7M
Cap. Flow
-$17.9M
Cap. Flow %
-1.78%
Top 10 Hldgs %
33.86%
Holding
786
New
7
Increased
79
Reduced
120
Closed
21
Avg Time Held
1.7 years
Top 10 Avg Time Held
2.5 years
Top 20 Avg Time Held
4.8 years

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$4.26M
2
ADBE icon
Adobe
ADBE
+$3.9M
3
ZTS icon
Zoetis
ZTS
+$3.65M
4
XOM icon
ExxonMobil
XOM
+$3.22M
5
GIS icon
General Mills
GIS
+$2.76M

Sector Composition

Rank Sector Weight
1 Technology 24.78%
2 Healthcare 15.82%
3 Financials 14.92%
4 Industrials 12.14%
5 Consumer Staples 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CNDT icon
751
Conduent
CNDT
$232M
$124 ﹤0.01%
85
– –
2025 Q3
3 quarters
HEDJ icon
752
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.74B
$114 ﹤0.01%
2
– –
2025 Q3
3 quarters
BTCS icon
753
BTCS Inc
BTCS
$59.8M
$111 ﹤0.01%
100
– –
2025 Q4
2 quarters
DLTR icon
754
Dollar Tree
DLTR
$22.8B
$102 ﹤0.01%
1
– –
2025 Q3
3 quarters
BNDX icon
755
Vanguard Total International Bond ETF
BNDX
$83.4B
$97 ﹤0.01%
2
– –
2025 Q3
3 quarters
ANGI icon
756
Angi Inc
ANGI
$248M
$89 ﹤0.01%
15
– –
2025 Q3
3 quarters
NOK icon
757
Nokia
NOK
$52.6B
$66 ﹤0.01%
5
– –
2025 Q3
3 quarters
GLIBA icon
758
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$795M
$66 ﹤0.01%
3
– –
2025 Q3
3 quarters
IVZ icon
759
Invesco
IVZ
$12.3B
$53 ﹤0.01%
2
– –
2025 Q3
3 quarters
WBD icon
760
DELISTED
Warner Bros
WBD
$53 ﹤0.01%
2
– –
2026 Q1
1 quarter
CGC icon
761
Canopy Growth
CGC
$302M
$52 ﹤0.01%
55
– –
2025 Q3
3 quarters
TAK icon
762
Takeda Pharmaceutical
TAK
$60.7B
$16 ﹤0.01%
1
– –
2025 Q3
3 quarters
CRON icon
763
Cronos Group
CRON
$1.16B
$6 ﹤0.01%
2
– –
2025 Q3
3 quarters
IMNN icon
764
Imunon
IMNN
$5.84M
$2 ﹤0.01%
1
– –
2025 Q3
3 quarters
OGI icon
765
Organigram Holdings
OGI
$130M
$1 ﹤0.01%
1
– –
2025 Q3
3 quarters
ATR icon
766
AptarGroup
ATR
$7.65B
– –
-50
Closed -$6.3K –
BPOP icon
767
Popular Inc
BPOP
$9.95B
– –
-118
Closed -$15.8K –
CAG icon
768
Conagra Brands
CAG
$6.61B
– –
-400
Closed -$6.29K –
CBFV icon
769
CB Financial Services
CBFV
$192M
– –
-49
Closed -$1.66K –
CTRA icon
770
DELISTED
Coterra Energy
CTRA
– –
-2,207
Closed -$77.6K –
DIOD icon
771
Diodes
DIOD
$3.99B
– –
-250
Closed -$17.1K –
DXC icon
772
DXC Technology
DXC
$2.04B
– –
-250
Closed -$3.14K –
ERTH icon
773
Invesco MSCI Sustainable Future ETF
ERTH
$120M
– –
-96
Closed -$4.53K –
FIVA icon
774
Fidelity International Value Factor ETF
FIVA
$620M
– –
-80
Closed -$2.79K –
KTB icon
775
Kontoor Brands
KTB
$3.8B
– –
-21
Closed -$1.48K –

Similar funds

Steigerwald Gordon & Koch's Q2 2026 Portfolio in Review

As of Q2 2026, Steigerwald Gordon & Koch held 786 positions worth $1.01B, up 3.6% from $974M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 3.6%. Steigerwald Gordon & Koch opened 7 new positions and exited 21, leaving the 786-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Steigerwald Gordon & Koch's largest Q2 2026 buy was Honeywell Aerospace: 219 shares worth $48.4K.
  • Steigerwald Gordon & Koch added most to Goldman Sachs in Q2 2026, an estimated $9.81M increase.
  • Steigerwald Gordon & Koch's biggest Q2 2026 reduction was T. Rowe Price, cutting an estimated $4.26M.
  • Steigerwald Gordon & Koch fully exited ExxonMobil in Q2 2026, selling an estimated $3.22M.
  • Steigerwald Gordon & Koch's ten largest holdings make up 34% of its $1.01B portfolio in Q2 2026.
  • Steigerwald Gordon & Koch opened 7 new positions and closed 21 in Q2 2026.
  • Steigerwald Gordon & Koch's portfolio value rose 3.6% quarter-over-quarter to $1.01B.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.